Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
402 Leser
Artikel bewerten:
(2)

In-Vitro Fertilization Microscopes Market to Reach $250.4 Million, Globally, by 2031 at 9.4% CAGR: Allied Market Research

Finanznachrichten News

The rise in prevalence of infertility among men and women, the surge in use of a variety of microscopes in clinical ART procedures, and innovations in microscopes which is increasing treatment efficiency drive the global in-vitro fertilization microscopes market.

PORTLAND, Ore., March 3, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "In-Vitro Fertilization Microscopes Market by Type (Upright Microscopes, Inverted Microscopes, Stereo Microscopes, Embryo Microscope), by End User (Clinical, Academic Research): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global in-vitro fertilization microscopes industry was valued at $105.4 million in 2021 and is estimated to generate $250.4 million by 2031, witnessing a CAGR of 9.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Allied_Market_Research_Logo

Download Free Sample Report:https://www.alliedmarketresearch.com/request-sample/31831

Drivers, Restraints, and Opportunities

The rise in prevalence of infertility among men and women and innovations in microscopes which is increasing treatment efficiency drive the in-vitro fertilization microscopes market. However, high cost of in-vitro fertilization microscopes hinders the global market growth. On the other hand, the surge in use of a variety of microscopes in clinical ART procedures, rise in awareness about IVF treatments, and increasing private investor investments in infertility clinics will present new growth opportunities for the global in-vitro fertilization microscopes market in the coming years.

Covid-19 Scenario

  • The outbreak of the COVID-19 pandemic negatively impacted various industries. The in-vitro fertilization microscope manufacturing companies ceased their operations owing to import-export restrictions, lockdowns, and labor shortage due to the fear of contracting the novel coronavirus, resulting in reduced market demand.
  • International fertility organizations suggested that except for necessary medical fertility preservation, IVF treatments need to be discontinued after the WHO declared the COVID-19 pandemic in March 2020. Consequently, fewer people chose to undergo IVF procedures, which had an impact on fertility clinics' need for supplies, equipment, and services.
  • IVF operations resumed after measures such as decontaminating & validating equipment, ensuring adequate staffing, and completing risk assessments were implemented.

Procure Complete Report (28 Pages PDF with Insights, Charts, Tables, and Figures) @https://www.alliedmarketresearch.com/checkout-final/ivfertilization-microscopes

The embryo microscope segment to grab lion's share during the forecast period

Based on type, the embryo microscope segment contributed to the largest share of more than one-third of the global in-vitro fertilization microscopes market in 2021 and is expected to maintain a noteworthy growth during the forecast period. The same segment is projected to witness the fastest CAGR of 10.0% from 2022 to 2031. This is because these systems display images of embryos and information about their growth patterns. This information enables embryologists to observe healthy embryo development and detect any issues with cell division timing that may occur during the early stages of growth.

The clinical segment to dominate the market during the forecast period

Based on end user, the clinical segment contributed to the largest share of three-fifths of the global in-vitro fertilization microscopes market in 2021 and is expected to maintain its leadership in terms of revenue during the forecast period. Moreover, the same segment is projected to witness the fastest CAGR of 9.7% from 2022 to 2031. IVF clinics offer a variety of services, including healthy oocyte identification, sperm analysis, ICSI, embryo monitoring, and embryo freezing & storage.

Europe to achieve the largest revenue by 2031

Based on region, the market in Europe was the largest in 2021, accounting for more than two-fifths of the global in-vitro fertilization microscopes market and is likely to maintain its dominance during the forecast timeframe. This is because companies in the region are implementing a variety of strategies, such as product launches and research initiatives. The presence of a large population as well as increased awareness of IVF are two important factors contributing to the market growth. However, the market in North America is likely to show the fastest CAGR of 10.2% during the forecast period. This is because of significant factors such as increased knowledge and availability of IVF services in the region.

Purchase Inquiry:https://www.alliedmarketresearch.com/purchase-enquiry/31831

Leading Market Players

  • Linkam Scientific Instruments
  • Olympus Corporation
  • Leica Microsystems
  • Meiji Techno
  • ZEISS International
  • Euromex Microscopen B.V.
  • Labomed Europe B.V.
  • Nikon Corporation
  • NARISHIGE Group.
  • Hamilton Thorne, Inc.

The report analyzes these key players of the global in-vitro fertilization microscopes market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2030

In Vitro Diagnostics Market By Product And Services (Reagents, Instruments, Software And Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), by End User (Standalone Laboratories, Hospitals, Academic And Medical Schools, Point Of Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

IVF Devices and Consumables Market by Product (Instruments, Accessories & Disposables, and Reagents & Media), Technology Type (Fresh Embryo IVF, Frozen Embryo IVF, and Donor Egg IVF), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2030

Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2022-2031

Electrocardiograph (ECG) Market By Product (Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Holter Monitors, Others), By End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), Others), By Lead Type (Single Lead ECG, 2 Lead ECG, 3 Lead ECG, 6 Lead ECG, 12-Lead ECG): Global Opportunity Analysis and Industry Forecast, 2020-2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/in-vitro-fertilization-microscopes-market-to-reach-250-4-million-globally-by-2031-at-9-4-cagr-allied-market-research-301761989.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.